+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Healthcare Contract Research Market Research and Forecast, 2019-2025

  • ID: 4770701
  • Report
  • Region: Global
  • Orion Market Research Private Limited
1 of 4


  • Clinipace, Inc.
  • JLL Partners, LLC
  • Medelis, Inc.
  • PRA Health Sciences, Inc.
  • Syneos Health, Inc.
  • MORE
Global Healthcare Contract Research Organizations (CRO) Market, Size, Share & Trends Analysis Report, By Services (Drug Discovery & Development, Pre-Clinical Services, Clinical Services, Risk Management & Pharmacovigilance, and Others Services), By Therapeutic Area (Cardiology, Autoimmune Diseases, Oncology, Neurology, Respiratory Diseases and Others) and Forecast, 2019-2025.

Healthcare CRO market has significant scope in pharmaceutical, biotechnology, and medical device industry since it reduces cost and time for clinical trial and drug development. CROs offers capabilities, for the growth of drug development, which includes pre-clinical R&D, clinical trials, monitoring and management, data management and analysis, study design, bio-statistical analysis, post-marketing surveillance, consulting, regulatory and safety assessment, and other services. The pharmaceutical companies, increasingly outsourcing critical functions, such as manufacturing and research. Use of CROs to lead clinical trials and develop new medications has been increased over the years.

Moreover, the major factors that are contributing towards the growth of the healthcare CRO market include rising demand for CRO, from pharmaceutical, biopharmaceutical, and medical device industries. Additionally, increasing outsourcing of R&D programs, rising R&D expenditures and growing number of clinical trials will drive the healthcare CRO market in near future. The CRO collaborations with government agencies and non-profit health organizations allows to expand clinical service providers, new drug development process and offers advanced healthcare outcomes. The CRO is considered as more affordable for companies to track new medications, however, pre-pursuing a drug approval is too expensive, and usually occurred as guaranteed approval for large markets. The presence of CROs is more cost-effective and allows companies to develop small drugs for niche audiences.

There are various companies involved in healthcare CRO market which includes Lambda Therapeutic Research, Ltd., PAREXEL International Corp., Pharmaceutical Product Development (PPD), LLC, Pharmaron Beijing Co., Ltd., LabCorp, and Syneos Health. Merger & acquisition, geographical expansion, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopted by major market players. For instance, in July 2017, LabCorp acquired Chiltern International, Ltd., which allows the company to strengthen its position as a global life sciences company with diagnostics and drug development businesses. The acquisition supports achieving a significant global scale. Chiltern International, Ltd., becomes the company’s Covance Drug Development business unit and expected to expand Covance offerings through focusing high-growth emerging and mid-market biopharma segments. The strategy of the company is to quickly offer innovative oncology medicine to a patient, that enables to improve patient outcomes. Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). Asia-Pacific demonstrates considerable potentials for collaborative and outsourced R&D in drug development, biotechnology, and medical devices. The increasing government initiatives, to promote the pharmaceutical sector, as it outsources the clinical development process to specialized CRO in the region enables to expand the CRO market.

Research Methodology

The market study of the global healthcare CRO market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases such as the IBEF, IFPMA, and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog.
The report is intended for research organizations, dental laboratories, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation:
1. Global Healthcare CRO Market Research and Analysis by Service
2. Global Healthcare CRO Market Research and Analysis by Therapeutic Area

The Report Covers:
  • Comprehensive research methodology of the global healthcare CRO market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global healthcare CRO market.
  • Insights about market determinants which are stimulating the global healthcare CRO market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 4


  • Clinipace, Inc.
  • JLL Partners, LLC
  • Medelis, Inc.
  • PRA Health Sciences, Inc.
  • Syneos Health, Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Laboratory Corporation of America Holdings (LabCorp) Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Charles River Laboratories International, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. PRA Health Sciences, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. IQVIA Holdings, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Syneos Health Overview Financial Analysis SWOT Analysis Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Healthcare CRO Market by Service
5.1.1. Drug Discovery & Development
5.1.2. Pre-Clinical Services
5.1.3. Clinical Services
5.1.4. Risk Management & Pharmacovigilance
5.1.5. Data Management & Technology Services
5.1.6. Post Marketing and Consulting Services
5.1.7. Other Services (Laboratory Services and Project Management)
5.2. Global Healthcare CRO Market by Therapeutic Area
5.2.1. Cardiology
5.2.2. Oncology
5.2.3. Neurology
5.2.4. Respiratory Diseases
5.2.5. Autoimmune Diseases
5.2.6. Others (Hematology & Gynecology)

6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7.1. Charles River Laboratories International Inc. (CRL)
7.2. Clinipace, Inc.
7.3. Fisher Clinical Services, Inc.
7.4. GVK Biosciences Pvt., Ltd.
7.5. HCL Technologies, Ltd.
7.6. ICON, PLC
7.7. IQVIA Holdings, Inc.
7.8. JLL Partners, LLC
7.9. LabCorp (Covance)
7.10. Lambda Therapeutic Research, Ltd.
7.11. Medelis, Inc.
7.12. Medpace, Inc.
7.13. PAREXEL International Corp.
7.14. Pharmaceutical Product Development, LLC
7.15. Pharmaron Beijing Co., Ltd.
7.16. PRA Health Sciences, Inc.
7.17. Premier Research International, LLC
7.18. QPS Holdings, LLC
7.19. Syneos Health, Inc.
7.20. Synteract, Inc.
7.21. Worldwide Clinical Trials Holdings, Inc.

* List of Tables and Figures available on enquiry
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Charles River Laboratories International Inc. (CRL)
  • Clinipace, Inc.
  • Fisher Clinical Services, Inc.
  • GVK Biosciences Pvt., Ltd.
  • HCL Technologies, Ltd.
  • IQVIA Holdings, Inc.
  • JLL Partners, LLC
  • LabCorp (Covance)
  • Lambda Therapeutic Research, Ltd.
  • Medelis, Inc.
  • Medpace, Inc.
  • PAREXEL International Corp.
  • Pharmaceutical Product Development, LLC
  • Pharmaron Beijing Co., Ltd.
  • PRA Health Sciences, Inc.
  • Premier Research International, LLC
  • QPS Holdings, LLC
  • Syneos Health, Inc.
  • Synteract, Inc.
  • Worldwide Clinical Trials Holdings, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4770701